Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02220608 · ClinicalTrials.gov registry record · Phase 1

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

A Phase 1 study of Multiple Myeloma, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target
1
Study location

NCT02220608 is a Phase 1 study of Multiple Myeloma that has completed, run by Washington University School of Medicine. The registered enrollment target is 10 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02220608, a Phase 1 study of Multiple Myeloma, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to determine the highest dose of a drug called bortezomib that can be given with a drug called G-CSF before stem cell collection to help in the mobilization of stem cells.

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG G-CSF
  • BIOLOGICAL Bortezomib

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-02-20
Est. Completion 2016-11-30
Phase Phase 1

Sponsor

Washington University School of Medicine

1,502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02220608

The ClinicalTrials.gov registry entry for NCT02220608 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (98% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 2 interventions - of which G-CSF is the first listed.

NCT02220608 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT02220608 about?

NCT02220608 is a clinical study titled "Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma". The purpose of this research study is to determine the highest dose of a drug called bortezomib that can be given with a drug called G-CSF before stem cell collection to help in the mobilization of stem cells.

What is the current status of trial NCT02220608?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-02-20. Estimated completion is 2016-11-30.

What conditions does trial NCT02220608 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT02220608?

The interventions under investigation include: G-CSF (DRUG), Bortezomib (BIOLOGICAL).

Who is sponsoring clinical trial NCT02220608?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02220608 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.